Parcourir par auteur "Papadimitriou, D."
Voici les éléments 1-9 de 9
-
Acute hypoadrenocorticism (adrenal crisis) in the dog: a report on six clinical cases
Kasabalis, D.; Soubasis, N.; Pardali, D.; Savas, I.; Pavlidou, K.; Petanides, T. A.; Papadimitriou, D.; Varlami, V.; Koutinas, A. F. (2011)Medical records of six dogs admitted with acute hypoadrenocorticism were reviewed. All 6 animals were bradycardic and had prolonged capillary refilling time. Hypothermia was detected in 5/6 animals. Clinicopathological ... -
Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease
Michelakakis, H.; Xiromerisiou, G.; Dardiotis, E.; Bozi, M.; Vassilatis, D.; Kountra, P. M.; Patramani, G.; Moraitou, M.; Papadimitriou, D.; Stamboulis, E.; Stefanis, L.; Zintzaras, E.; Hadjigeorgiou, G. M. (2012)Lysosomal protein 2 (LIMP2), the product of the scavenger receptor class B member 2 (SCARB2) gene, is a ubiquitously expressed transmembrane protein that is the mannose-6-phosphateindependent receptor for glucocerebrosidase ... -
Genetic assessment of familial and early-onset Parkinson's disease in a Greek population
Bozi, M.; Papadimitriou, D.; Antonellou, R.; Moraitou, M.; Maniati, M.; Vassilatis, D. K.; Papageorgiou, S. G.; Leonardos, A.; Tagaris, G.; Malamis, G.; Theofilopoulos, D.; Kamakari, S.; Stamboulis, E.; Hadjigeorgiou, G. M.; Athanassiadou, A.; Michelakakis, H.; Papadimitriou, A.; Gasser, T.; Stefanis, L. (2014)Background and purpose Although the first mutation associated with Parkinson's disease (PD) was identified several years ago in the alpha-synuclein (SNCA) gene in families of Greek and Italian ancestry, a more systematic ... -
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis
Hadjigeorgiou, G. M.; Doxani, C.; Miligkos, M.; Ziakas, P.; Bakalos, G.; Papadimitriou, D.; Mprotsis, T.; Grigoriadis, N.; Zintzaras, E. (2013)What is known and objectiveThe relative effectiveness and safety profile of the treatments with marketing authorization for relapsing multiple sclerosis (MS) are not well known because randomized controlled trials with ... -
A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality
Crimi, M.; Papadimitriou, A.; Galbiati, S.; Palamidou, P.; Fortunato, F.; Bordoni, A.; Papandreou, U.; Papadimitriou, D.; Hadjigeorgiou, G. M.; Drogari, E.; Bresolin, N.; Comi, G. P. (2004)We describe a new mitochondrial DNA mutation in a male infant who presented clinical and magnetic resonance imaging features of Leigh syndrome and died at the age of 9 mo. The patient's development was reportedly normal ... -
Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA)
Hadjigeorgiou, G.; Dardiotis, E.; Tsivgoulis, G.; Doskas, T.; Petrou, D.; Makris, N.; Vlaikidis, N.; Thomaidis, T.; Kyritsis, A.; Fakas, N.; Treska, X.; Karageorgiou, C.; Sotirli, S.; Giannoulis, C.; Papadimitriou, D.; Mylonas, I.; Kouremenos, E.; Vlachos, G.; Georgiopoulos, D.; Mademtzoglou, D.; Vikelis, M.; Zintzaras, E. (2014)Multiple sclerosis (MS) results in an extensive use of the health care system, even within the first years of diagnosis. The effectiveness and accessibility of the health care system may affect patients' quality of life. ... -
Peripheral alpha-synuclein markers in subjects harboring the G209A mutation in the SNCA gene
Emmanouilidou, E.; Antonelou, R.; Papadimitriou, D.; Maniati, M.; Papagiannakis, N.; Stamelou, M.; Tagaris, G.; Papageorgiou, S.; Kapaki, E.; Leonardos, N.; Ioannou, P.; Bostantjopoulou, S.; Papadimitriou, A.; Athanassiadou, A.; Vekrellis, K.; Stefanis, L. (2014) -
Phenotypic spectrum of SNCA G209A mutation carriers for familial Parkinson's disease in Greece
Papadimitriou, D.; Antonelou, R.; Stamelou, M.; Bozi, M.; Maniati, M.; Papagiannakis, N.; Bostantjopoulou, S.; Leonardos, A.; Papageorgiou, S.; Hadjigeorgiou, G.; Kapaki, E.; Tagaris, G.; Papadimitriou, A.; Athanassiadou, A.; Stefanis, L. (2014) -
Positron emission tomography changes in PARK1 mutation
Perani, D.; Garibotto, V.; Hadjigeorgiou, G. M.; Papadimitriou, D.; Fazio, F.; Papadimitriou, A. (2006)